SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-037311
Filing Date
2021-02-11
Accepted
2021-02-11 07:15:59
Documents
5
Period of Report
2021-02-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d131740d8k.htm 8-K 23729
2 EX-10.1 d131740dex101.htm EX-10.1 53962
3 EX-10.2 d131740dex102.htm EX-10.2 60104
4 EX-99.1 d131740dex991.htm EX-99.1 10630
5 GRAPHIC g131740g0211040724734.jpg GRAPHIC 6299
  Complete submission text file 0001193125-21-037311.txt   158492
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38459 | Film No.: 21616678
SIC: 2836 Biological Products, (No Diagnostic Substances)